Patient Perspectives on Managing Adverse Effects from Capecitabine, Trastuzumab, and Tucatinib

Panelists discuss the adverse effects experienced by a patient undergoing treatment with capecitabine (Xeloda), trastuzumab (Herceptin), and tucatinib (Tukysa), along with the strategies employed to manage those adverse effects, while also addressing patient follow-up procedures, including the frequency of visits, typical labs and imaging ordered, concerning symptoms and lab results, and the outcomes of the patient's most recent follow-up appointment.

EP: 1.Overview of HER2 Breast Cancer

EP: 2.HER2+ Breast Cancer Diagnosis: Insights From Patients and Clinicians

EP: 3.Coordinating Care for HER+ Breast Cancer Patients: A Multidisciplinary Approach

EP: 4.Multidisciplinary Care of HER2+ Breast Cancer: A Patient Perspective

EP: 5.Tailoring Patient Education and Resources in HER2+ Breast Cancer

EP: 6.Navigating HER2+ Breast Cancer Treatment: A Patient's Journey

EP: 7.Navigating Systemic Therapy Options in HER2+ Breast Cancer

EP: 8.Key Insights from the HER2CLIMB Trial

EP: 9.Key Insights From the DEBBRAH and HER2CLIMB-02 Studies

EP: 10.BRIDGET Trial: Strategies in Maintenance Therapy for HER2+ Breast Cancer with Brain Metastases

EP: 11.Preparing Patients for Treatment: Education, Administration and Adverse Effect Management in HER2+ Breast Cancer

Now Viewing

EP: 12.Patient Perspectives on Managing Adverse Effects from Capecitabine, Trastuzumab, and Tucatinib

1. Dr Iyengar asks Dorian Nygard: What side adverse effects have you experienced with your current treatment (capecitabine [Zeloda], trastuzumab [Herceptin], and tucatinib [Tukysa])?
   1. What strategies have you found to be most helpful in managing these side adverse effects?
2. Dr Iyengar asks Odessa Williams: Describe patient follow-up procedures in your practice.
   1. How often do you see your patients for follow-up at your institution
   2. What labs and imaging are typically ordered and at what frequency?
   3. During follow-up, what symptoms or labs are most concerning to you?
3. Dr Iyengar asks Dorian Nygard: What was the outcome of your most recent follow-up appointment?

Recent Videos